Anthera Pharmaceuticals Inc (NASDAQ:ANTH)
| 0.585 Data as of 10:09am ET |  +0.005 / +0.86%Today’s Change | 0.49 Today|||52-Week Range 3.21 | -5.65% Year-to-Date |
Latest ANTH News | Press Releases
No recent news for Anthera Pharmaceuticals Inc.
Today’s Trading
| Previous close | 0.58 |
| Today’s open | 0.58 |
| Day’s range | 0.58 - 0.61 |
| Volume | 55,150 |
| Average volume (3 months) | 790,865 |
| Market cap | $88.5M |
| Dividend yield | -- |
Data as of 10:09am ET, 05/21/2013
Growth & Valuation
| Earnings growth (last year) | +59.61% |
| Earnings growth (this year) | +76.21% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PRANPrana Biotechnology ... | 0.00 | 0.00% |
| CPIXCumberland Pharmaceu... | -0.08 | -1.55% |
| DSCODiscovery Laboratori... | 0.00 | 0.00% |
| OGENOragenics Inc | 0.00 | 0.00% |
Data as of 10:25am ET, 05/21/2013
Financials
| Last reporting date | May 14, 2013 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$59.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Paul F. Truex, MBA |
CFO, Chief Business Officer & VP-Administration Christopher P. Lowe, MBA |
Corporate headquarters Hayward, California |
Forecasts
